No Data
No Data
Lipocine Announces The Publication And Discussion Of A Manuscript "Oral LPCN 1148 Improves Sarcopenia And Hepatic Encephalopathy In Male Patients With Cirrhosis: A Randomized, Placebo-controlled Phase 2 Trial" In The Journal Hepatology And Discussion...
Express News | Lipocine Announces Publication and Discussion of Lpcn 1148 Manuscript at the Liver Meeting 2024 Editor's Cut Session
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
Lipocine Shares Are Trading Lower. The Company Reported Q3 Financial Results.
Express News | Lipocine Shares Are Trading Lower. The Company Reported Q3 Financial Results
Lipocine | 8-K: Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
No Data
No Data